ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978

Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed

May 14, 1993

NIH Not Proactive, Healy Tells NCAB ‘Beset’ By Issues

February 12, 1993

In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned

August 18, 1989

In Brief: NCAB Committee Worried About Requirements for Comprehensive Centers, To Meet Again

May 27, 1988

Oncology Nurses Urged To Help Set Agenda For Health Care Reform

May 29, 1992